Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension

Completed · Phase 4

Conditions studied: Ocular Hypertension, Glaucoma

In brief

The study will compare the safety and efficacy of Bimatoprost and Latanoprost in patients with glaucoma or ocular hypertension

Key facts

Study ID

NCT00541242

Run by

Allergan

People needed

586

Starts

2007-12-01

Expected to finish

2008-08-01

Last updated by the study team

2011-10-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ocular hypertension or chronic glaucoma
• Patient requires IOP-lowering therapy in both eyes

You may not qualify if…

• Uncontrolled medical conditions
• Hypersensitivity to study medications

Where it is running

• Study site — Newport Beach, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.